NO781050L - Nye cephalosporiner, samt fremgangsmaate ved fremstilling av disse - Google Patents

Nye cephalosporiner, samt fremgangsmaate ved fremstilling av disse

Info

Publication number: NO781050L
Authority: NO; Norway
Prior art keywords: group; formula; hydrogen; compound; amino
Prior art date: 1977-03-26

Application number

NO781050A

Other languages

English (en)

Norwegian (no)

Inventor

Giorgio Palamidessi

Maurizio Foglio

Franco Zarini

Giovanni Franceschi

Aurora Sanfilippo

Federico Arcamone

Original Assignee

Farmaceutici Italia

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1977-03-26

Filing date

1978-03-22

Publication date

1978-09-27

1978-03-22 Application filed by Farmaceutici Italia filed Critical Farmaceutici Italia

1978-09-27 Publication of NO781050L publication Critical patent/NO781050L/no

Links

238000000034 method Methods 0.000 title claims description 13
229940124587 cephalosporin Drugs 0.000 title claims description 9
229930186147 Cephalosporin Natural products 0.000 title claims description 6
238000002360 preparation method Methods 0.000 title claims description 3
HOKIDJSKDBPKTQ-GLXFQSAKSA-N cephalosporin C Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H](N)C(O)=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-N 0.000 title description 2
150000001875 compounds Chemical class 0.000 claims description 16
-1 cyanomethyl Chemical group 0.000 claims description 12
229910052739 hydrogen Inorganic materials 0.000 claims description 12
239000001257 hydrogen Substances 0.000 claims description 11
150000002431 hydrogen Chemical group 0.000 claims description 8
150000001780 cephalosporins Chemical class 0.000 claims description 5
ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 claims description 5
125000003545 alkoxy group Chemical group 0.000 claims description 4
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
229910052736 halogen Inorganic materials 0.000 claims description 4
150000002367 halogens Chemical group 0.000 claims description 4
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
238000004519 manufacturing process Methods 0.000 claims description 4
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 4
238000006243 chemical reaction Methods 0.000 claims description 3
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
IXZDIALLLMRYOU-UHFFFAOYSA-N tert-butyl hypochlorite Chemical compound CC(C)(C)OCl IXZDIALLLMRYOU-UHFFFAOYSA-N 0.000 claims description 3
125000003282 alkyl amino group Chemical group 0.000 claims description 2
125000004414 alkyl thio group Chemical group 0.000 claims description 2
125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
125000005518 carboxamido group Chemical group 0.000 claims description 2
239000003795 chemical substances by application Substances 0.000 claims description 2
JILPJDVXYVTZDQ-UHFFFAOYSA-N lithium methoxide Chemical compound [Li+].[O-]C JILPJDVXYVTZDQ-UHFFFAOYSA-N 0.000 claims description 2
HRDXJKGNWSUIBT-UHFFFAOYSA-N methoxybenzene Chemical group [CH2]OC1=CC=CC=C1 HRDXJKGNWSUIBT-UHFFFAOYSA-N 0.000 claims description 2
125000005633 phthalidyl group Chemical group 0.000 claims description 2
238000003756 stirring Methods 0.000 claims description 2
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
BSYVTEYKTMYBMK-UHFFFAOYSA-N tetrahydrofurfuryl alcohol Chemical compound OCC1CCCO1 BSYVTEYKTMYBMK-UHFFFAOYSA-N 0.000 claims description 2
125000005301 thienylmethyl group Chemical group [H]C1=C([H])C([H])=C(S1)C([H])([H])* 0.000 claims description 2
125000006000 trichloroethyl group Chemical group 0.000 claims description 2
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
238000002955 isolation Methods 0.000 claims 3
125000000217 alkyl group Chemical group 0.000 claims 2
CKNQOKQJFOLEAP-UHFFFAOYSA-N (hydroxyamino)oxysulfonylformic acid Chemical group ONOS(=O)(=O)C(=O)O CKNQOKQJFOLEAP-UHFFFAOYSA-N 0.000 claims 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
125000004093 cyano group Chemical group *C#N 0.000 claims 1
125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 1
235000013312 flour Nutrition 0.000 claims 1
125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 claims 1
239000011541 reaction mixture Substances 0.000 claims 1
125000005031 thiocyano group Chemical group S(C#N)* 0.000 claims 1
125000003396 thiol group Chemical class [H]S* 0.000 claims 1
230000007306 turnover Effects 0.000 claims 1
125000003373 pyrazinyl group Chemical group 0.000 description 7
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
125000001544 thienyl group Chemical group 0.000 description 6
101150041968 CDC13 gene Proteins 0.000 description 5
HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 5
239000000243 solution Substances 0.000 description 5
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
150000002148 esters Chemical class 0.000 description 4
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
239000002253 acid Substances 0.000 description 3
125000003118 aryl group Chemical group 0.000 description 3
239000000203 mixture Substances 0.000 description 3
HKAVADYDPYUPRD-UHFFFAOYSA-N 1h-pyrazine-2-thione Chemical class SC1=CN=CC=N1 HKAVADYDPYUPRD-UHFFFAOYSA-N 0.000 description 2
241000588697 Enterobacter cloacae Species 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
241000588724 Escherichia coli Species 0.000 description 2
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
230000000694 effects Effects 0.000 description 2
229940088598 enzyme Drugs 0.000 description 2
230000007062 hydrolysis Effects 0.000 description 2
238000006460 hydrolysis reaction Methods 0.000 description 2
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
239000007787 solid Substances 0.000 description 2
AUENQRMLHKNCRE-VLHGOJDXSA-N (6R)-4-acetamido-4-benzhydryl-3-[(3-methoxypyrazin-2-yl)sulfanylmethyl]-8-oxo-7-thiophen-2-yl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound CC(=O)NC1(C(=C(N2[C@H](S1)C(C2=O)C3=CC=CS3)C(=O)O)CSC4=NC=CN=C4OC)C(C5=CC=CC=C5)C6=CC=CC=C6 AUENQRMLHKNCRE-VLHGOJDXSA-N 0.000 description 1
JHWOBKLTTLRWML-YYGLIYBVSA-N (6R)-4-acetamido-4-benzhydryl-8-oxo-3-(pyrazin-2-ylsulfanylmethyl)-7-thiophen-2-yl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound CC(=O)NC1(C(=C(N2[C@H](S1)C(C2=O)C3=CC=CS3)C(=O)O)CSC4=NC=CN=C4)C(C5=CC=CC=C5)C6=CC=CC=C6 JHWOBKLTTLRWML-YYGLIYBVSA-N 0.000 description 1
WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
FADWHMWTUOKTMV-UHFFFAOYSA-N 6-methoxy-1h-pyrazine-2-thione Chemical compound COC1=CN=CC(S)=N1 FADWHMWTUOKTMV-UHFFFAOYSA-N 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
150000008065 acid anhydrides Chemical class 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
150000001540 azides Chemical class 0.000 description 1
PKOMXLRKGNITKG-UHFFFAOYSA-L calcium;hydroxy(methyl)arsinate Chemical compound [Ca+2].C[As](O)([O-])=O.C[As](O)([O-])=O PKOMXLRKGNITKG-UHFFFAOYSA-L 0.000 description 1
MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 description 1
229960001139 cefazolin Drugs 0.000 description 1
HOKIDJSKDBPKTQ-GLXFQSAKSA-M cephalosporin C(1-) Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H]([NH3+])C([O-])=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-M 0.000 description 1
238000001816 cooling Methods 0.000 description 1
239000013078 crystal Substances 0.000 description 1
NPOMSUOUAZCMBL-UHFFFAOYSA-N dichloromethane;ethoxyethane Chemical compound ClCCl.CCOCC NPOMSUOUAZCMBL-UHFFFAOYSA-N 0.000 description 1
229940079919 digestives enzyme preparation Drugs 0.000 description 1
CCGKOQOJPYTBIH-UHFFFAOYSA-N ethenone Chemical compound C=C=O CCGKOQOJPYTBIH-UHFFFAOYSA-N 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
238000001914 filtration Methods 0.000 description 1
230000003301 hydrolyzing effect Effects 0.000 description 1
238000011534 incubation Methods 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
239000000543 intermediate Substances 0.000 description 1
239000013067 intermediate product Substances 0.000 description 1
239000010410 layer Substances 0.000 description 1
UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
238000006198 methoxylation reaction Methods 0.000 description 1
GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical compound [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
125000006502 nitrobenzyl group Chemical group 0.000 description 1
239000012044 organic layer Substances 0.000 description 1
239000012074 organic phase Substances 0.000 description 1
230000020477 pH reduction Effects 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
239000000047 product Substances 0.000 description 1
OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 1
238000010992 reflux Methods 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
239000012047 saturated solution Substances 0.000 description 1
125000000542 sulfonic acid group Chemical group 0.000 description 1
239000000725 suspension Substances 0.000 description 1
150000003573 thiols Chemical class 0.000 description 1
238000005406 washing Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/57—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with a further substituent in position 7, e.g. cephamycines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Cephalosporin Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

NO781050A 1977-03-26 1978-03-22 Nye cephalosporiner, samt fremgangsmaate ved fremstilling av disse NO781050L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB12819/77A GB1579533A (en)	1977-03-26	1977-03-26	Cephalosporins and their preparation

Publications (1)

Publication Number	Publication Date
NO781050L true NO781050L (no)	1978-09-27

Family

ID=10011720

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO781050A NO781050L (no)	1977-03-26	1978-03-22	Nye cephalosporiner, samt fremgangsmaate ved fremstilling av disse

Country Status (22)

Country	Link
US (1)	US4206211A (fr)
JP (1)	JPS53121790A (fr)
AT (1)	AT359189B (fr)
AU (1)	AU514878B2 (fr)
BE (1)	BE865175A (fr)
CA (1)	CA1098118A (fr)
CH (1)	CH637966A5 (fr)
CS (1)	CS202594B2 (fr)
DE (1)	DE2812626A1 (fr)
DK (1)	DK127878A (fr)
FR (1)	FR2384784A1 (fr)
GB (1)	GB1579533A (fr)
GR (1)	GR62540B (fr)
IE (1)	IE46712B1 (fr)
IL (1)	IL54203A (fr)
NL (1)	NL7803282A (fr)
NO (1)	NO781050L (fr)
NZ (1)	NZ186619A (fr)
SE (1)	SE7803388L (fr)
SU (1)	SU882413A3 (fr)
YU (1)	YU60978A (fr)
ZA (1)	ZA781283B (fr)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3821207A (en) *	1971-06-21	1974-06-28	Smithkline Corp	7-heterocyclic substituted cephalosporins
BE787635A (fr) *	1971-08-20	1973-02-19	Takeda Chemical Industries Ltd	Cephalosporines
US3984403A (en) *	1972-06-30	1976-10-05	Takeda Chemical Industries, Ltd.	Arginine and lysine salts of acid cephalosporins
GB1449420A (en) *	1973-11-26	1976-09-15	Sankyo Co	7alpha-methoxycephalosporing derivatives
US4059578A (en) *	1974-09-09	1977-11-22	Smithkline Corporation	7-Substituted mercaptoacetamido cephamycins
DK154939C (da) *	1974-12-19	1989-06-12	Takeda Chemical Industries Ltd	Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
DE2539214C2 (de) *	1975-09-03	1984-03-29	E.R. Squibb & Sons, Inc., 08540 Princeton, N.J.	7-Methoxythienyl-ureido-cephalosporin und dieses enthaltendes Arzneimittel
US4128723A (en) *	1977-02-02	1978-12-05	E. R. Squibb & Sons, Inc.	Cyanoalkylureido cephalosporins

1977
- 1977-03-26 GB GB12819/77A patent/GB1579533A/en not_active Expired
1978
- 1978-03-03 NZ NZ186619A patent/NZ186619A/xx unknown
- 1978-03-06 CH CH237878A patent/CH637966A5/it not_active IP Right Cessation
- 1978-03-06 ZA ZA00781283A patent/ZA781283B/xx unknown
- 1978-03-06 IL IL54203A patent/IL54203A/xx unknown
- 1978-03-10 US US05/885,126 patent/US4206211A/en not_active Expired - Lifetime
- 1978-03-14 GR GR55706A patent/GR62540B/el unknown
- 1978-03-17 AU AU34244/78A patent/AU514878B2/en not_active Expired
- 1978-03-21 CS CS781786A patent/CS202594B2/cs unknown
- 1978-03-21 IE IE566/78A patent/IE46712B1/en unknown
- 1978-03-21 DK DK127878A patent/DK127878A/da not_active Application Discontinuation
- 1978-03-22 BE BE186166A patent/BE865175A/fr not_active IP Right Cessation
- 1978-03-22 FR FR7808271A patent/FR2384784A1/fr active Granted
- 1978-03-22 DE DE19782812626 patent/DE2812626A1/de not_active Ceased
- 1978-03-22 NO NO781050A patent/NO781050L/no unknown
- 1978-03-23 CA CA299,694A patent/CA1098118A/fr not_active Expired
- 1978-03-23 SE SE7803388A patent/SE7803388L/xx unknown
- 1978-03-24 JP JP3399878A patent/JPS53121790A/ja active Pending
- 1978-03-24 SU SU782594352A patent/SU882413A3/ru active
- 1978-03-24 AT AT213078A patent/AT359189B/de not_active IP Right Cessation
- 1978-03-28 NL NL7803282A patent/NL7803282A/xx unknown
- 1978-12-28 YU YU00609/78A patent/YU60978A/xx unknown

Also Published As

Publication number	Publication date
FR2384784B1 (fr)	1982-05-28
IL54203A0 (en)	1978-06-15
IE46712B1 (en)	1983-09-07
CS202594B2 (en)	1981-01-30
GR62540B (en)	1979-05-04
BE865175A (fr)	1978-09-22
JPS53121790A (en)	1978-10-24
NL7803282A (en)	1978-09-28
DK127878A (da)	1978-09-27
IL54203A (en)	1981-05-20
DE2812626A1 (de)	1978-09-28
AU3424478A (en)	1979-09-20
AU514878B2 (en)	1981-03-05
SE7803388L (sv)	1978-09-27
ZA781283B (en)	1979-02-28
GB1579533A (en)	1980-11-19
CA1098118A (fr)	1981-03-24
FR2384784A1 (fr)	1978-10-20
IE780566L (en)	1978-09-26
US4206211A (en)	1980-06-03
NZ186619A (en)	1979-10-25
AT359189B (de)	1980-10-27
YU60978A (en)	1983-01-21
CH637966A5 (it)	1983-08-31
ATA213078A (de)	1980-03-15
SU882413A3 (ru)	1981-11-15

Publication	Publication Date	Title
KR840000797B1 (ko)	1984-06-12	6β-하이드록시알킬페니실란산 유도체의 제조방법
EP0005889B1 (fr)	1982-06-16	Procédé de préparation de dérivés de bêta-lactame, les nouveaux dérivés ainsi obtenus et compositions pharmaceutiques les contenant
NO173016B (no)	1993-07-05	Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-laktamderivater
JPS6124396B2 (fr)	1986-06-10
NO774180L (no)	1978-06-09	Fremgangsmaate for fremstilling av cefalosporin- og penicillinderivater
NO170021B (no)	1992-05-25	Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-propenylcefem-derivater
NO773081L (no)	1978-03-09	Nye bicykliske forbindelser.
US4356174A (en)	1982-10-26	Beta-lactamase inhibiting 2-beta-substituted-2-alpha-methyl-(5R)penam-3-alpha-carboxylic acid 1,1-dioxides and intermediates therefor
KR840000589B1 (ko)	1984-04-24	6-β-치환된 페니실란산의 제조방법
US4166816A (en)	1979-09-04	Methods and intermediates for preparing cis-4-oxoazetidine intermediates
NO781050L (no)	1978-09-27	Nye cephalosporiner, samt fremgangsmaate ved fremstilling av disse
NO831057L (no)	1982-09-24	Fremgangsmaate for fremstilling av lett hydrolyserbare estere som nedbrytes in vivo til beta-laktam-antibiotika og beta-laktamase-inhibitoren penicillansyre-sulfon
Yanagisawa et al.	1976	Synthesis of 7α-substituted cephalosporins. V Novel oxidation procedure for syntheses of 7α-methoxycephalosporins and 6α-methoxypenicillins
US3941779A (en)	1976-03-02	Method for producing 2-(substituted thio)-3-cephem derivatives
US4072674A (en)	1978-02-07	Cis-4-oxoazetidine intermediates and methods of preparing them
NO752034L (fr)	1975-12-15
NO833415L (no)	1983-07-12	Fremgangsmaate for fremstilling av 6-aminoalkylpenicillansyre-1,1-dioksyder
NO743991L (fr)	1975-06-02
KR870000313B1 (ko)	1987-02-26	6-(아미노메틸)페니실란산 1,1-다이옥사이드 및 이의 유도체의 제조방법
US4257947A (en)	1981-03-24	3-Amino-2-hydroxy, halo or mercaptomethyl-4-oxoazetidines
US4169833A (en)	1979-10-02	Novel phosphorane intermediates for use in preparing penem antibiotics
Singh et al.	1989	Desulfation and rearrangement of tigemonam to an isoxazolidin‐5‐one and the synthesis of the rearrangement product
Roets et al.	1977	PREPARATION OF 6-EPI-AMPICILLIN AND OF 6-EPI-α-HYD ROXYBENZYLPENICI LLIN
NO780509L (no)	1977-12-28	Mellomprodukt for anvendelse ved fremstilling av en terapeutisk aktiv forbindelse
JPH039115B2 (fr)	1991-02-07